The Press Room

Healio Do you understand how clinical trials work in oncology? Wasif Saif, M.D., MBBS , medical oncologist, leader of the  Phase I Clinical Trials Multidisciplinary Team (MDT) and co-leader of the  Gastrointestinal and Neuroendocrine Oncology MDT , debunked a common myth about clinical trials for cancer and explained why there are no placebos in phase I trials. Read the article here . Learn more about clinical trials at Karmanos here .

WebMD Breast cancer survivors have turned the in-person support group into a thread on Reddit. Researchers at the University of Colorado Anschutz Medical Campus in Denver found themes of advice, affirmation, venting, solidarity, and motivation, among other topics discussed in over 700 posts. Though peer support is present, Mary Morreale, M.D. , clinical psychiatrist and member of the Supportive Oncology Multidisciplinary Team at Karmanos, explained why survivors will need to find a delicate balance with...

Patient Power The liver plays a crucial role in the health of our skin, among its other duties. Anthony Shields, M.D., Ph.D. , medical oncologist and member of the  Gastrointestinal and Neuroendocrine Oncology  and the  Phase 1 Clinical Trials  Multidisciplinary Teams at Karmanos, explained skin conditions that some liver cancer patients may experience. Read the article here .

GQ Anthony Shields, M.D., Ph.D. , medical oncologist and member of the  Gastrointestinal and Neuroendocrine Oncology  and the  Phase 1 Clinical Trials  Multidisciplinary Teams at Karmanos, spoke to GQ about the imaging process for cancer screenings and his thoughts on full-body scans. Read the article here .

Newsweek Though the recommended age to begin receiving colonoscopies is 45, there has been a noticeable amount of people being diagnosed with colorectal cancer at even younger ages. Wasif Saif, M.D., MBBS , medical oncologist, co-leader of the  Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team  (MDT) and leader of the  Phase I Clinical Trials MDT , explained the symptoms and risk factors of colorectal cancer that people of average and high-risk need to know, including ho...

101 WRIF November is Lung Cancer Awareness Month. David Sternberg, M.D. , cardiothoracic surgeon and member of the Thoracic Oncology Multidisciplinary Team at Karmanos, spoke to Meltdown on 101 WRIF about lung cancer risks, screening and the advancements in treatment that are available to treat the disease. He described two main causes of lung cancer development: smoking and radon gas. Your browser does not support the audio element. Download Podcast

The Barbara Ann Karmanos Cancer Institute , cancer centers, and other organizations nationwide recognize November as Pancreatic Cancer Awareness Month. As its name indicates, pancreatic cancer originates in the pancreas, an organ that sits behind the stomach. The pancreas aids in digestion and helps regulate blood sugar. About Pancreatic Cancer Exocrine cells make up much of the pancreas. When these cells grow out of control, adenocarcinoma of the pancreas occurs. Pancreatic adenocarcinomas account for ...

The Barbara Ann Karmanos Cancer Institute , cancer centers, and other organizations nationwide recognize November as Lung Cancer Awareness Month. Lung cancer is the second most common cancer among women and men, not including skin cancer. For women, breast cancer is more common, while prostate cancer is the most common cancer for men. Lung Cancer Facts and Figures About 234,580 new cases of lung cancer will be diagnosed in 2024. About 125,070 deaths will result from lung cancer in 2024. Lung cancer is t...

Becker’s Healthcare Podcast Boris Pasche, M.D., Ph.D., FACP , president and CEO of the Barbara Ann Karmanos Cancer Institute, joined the Becker’s Healthcare Podcast to discuss advances in cancer treatment. He highlighted advances in theranostics, immunotherapy, and using electromagnetic radio frequencies to treat cancer. Dr. Pasche explained how these therapies are giving cancer patients more hope and improving outcomes. Your browser does not support the audio element. Download Podcast

The Barbara Ann Karmanos Cancer Institute welcomes Hassan Nasser, M.D. , an otolaryngologist and surgical oncologist who specializes in head and neck cancers. Dr. Nasser is part of the Head and Neck Oncology Multidisciplinary Team (MDT) at Karmanos and is now accepting new patients at the Karmanos Cancer Center in Detroit and Karmanos Cancer Institute – Roseville . He joined Karmanos on May 1, 2024. “One of the qualities that drove me toward the Head and Neck MDT and Karmanos is the team that has develo...